Vasculitis & polymyalgia rheumatica

Elevated serum immunoglobulin level predicts high risk of 1-year recurrence in patients with Takayasu arteritis

Arthritis Res TherPublished Retrospective cohort study

Authors' conclusion

Immunoglobulins is of clinical value in evaluating disease activity in TAK patients. Moreover, the dynamic changes of IgG were correlated with the changes in inflammatory indicators in TAK patients.

Study context

Population
Patients with TAK; 120 in remission within 3 months after discharge followed up for 1 year120 followed up 1 year
Participants
190 patients
Exposure
Elevated vs normal immunoglobulins
Outcome
Disease activity
Methodological detailslogistic regression, immunohistochemical comparison with atherosclerotic patients
  • Logistic regression
  • Immunohistochemical comparison with atherosclerotic patients

Main finding

As reported in the abstract

GroupValueITAS-A
Elevated immunoglobulins3.09.0
Normal2.07.0

Value

Elevated immunoglobulins3.0
Normal2.0

ITAS-A

Elevated immunoglobulins9.0
Normal7.0
  • Elevated immunoglobulins vs Normal: P = 0.001
  • Elevated immunoglobulins vs Normal: P = 0.006

Observational data: associations, not effects.

Further findings

OutcomeOR for 1-year recurrence (95% CI)P value
1-year recurrence in TAK patients in remission within 3 months after discharge (n=120), elevatedvs normal immunoglobulinsLogistic regression2.37 (1.03–5.47)P = 0.042
OutcomeP value
CD138+ plasma cells in the aortic wall (immunohistochemistry), TAK vs atherosclerotic patientsSignificantly increased in TAKP = 0.021

Correlation of changes in IgG with CRP and ESR

IgG change vs CRP, Pearson r (P = 0.027)
0.40
IgG change vs ESR, Pearson r (P < 0.001)
0.64

Original publication

Elevated serum immunoglobulin level predicts high risk of 1-year recurrence in patients with Takayasu arteritis. Arthritis Res Ther. Published 7 March 2023. doi:10.1186/s13075-023-03016-8

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.